<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0120-5633</journal-id>
<journal-title><![CDATA[Revista Colombiana de Cardiología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Colomb. Cardiol.]]></abbrev-journal-title>
<issn>0120-5633</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Colombiana de Cardiologia. Oficina de Publicaciones]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0120-56332024000600329</article-id>
<article-id pub-id-type="doi">10.24875/rccar.24000088</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Importancia de la estandarización de los reportes del perfil lipídico en los laboratorios clínicos]]></article-title>
<article-title xml:lang="en"><![CDATA[Importance of standardized lipid profile reporting in clinical laboratories]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[Ángel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Arango]]></surname>
<given-names><![CDATA[Javier]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cabrera]]></surname>
<given-names><![CDATA[Javier]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Melo]]></surname>
<given-names><![CDATA[Jaime]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Miranda]]></surname>
<given-names><![CDATA[Harold]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Restrepo]]></surname>
<given-names><![CDATA[Katherine]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
<xref ref-type="aff" rid="A a"/>
<xref ref-type="aff" rid="A10"/>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vélez]]></surname>
<given-names><![CDATA[Marlene I.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mojica]]></surname>
<given-names><![CDATA[Iván L.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[Jaime A.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="A a"/>
<xref ref-type="aff" rid="A15"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Universitario San Ignacio Unidad de Cardiología, Pontificia Universidad Javeriana Departamento de Medicina Interna]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Asociación Colombiana de Medicina Interna Asociación Colombiana de Medicina Interna ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Asociación Colombiana de Gerontología y Geriatría Asociación Colombiana de Gerontología y Geriatría ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Centros Médicos Keralty Dirección Científica ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Sociedad Colombiana de Medicina Familiar Sociedad Colombiana de Medicina Familiar, Bogotá ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af6">
<institution><![CDATA[,Asociación Colombiana de Medicina Vascular (ACMV) Asociación Colombiana de Medicina Vascular (ACMV) ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af7">
<institution><![CDATA[,Diagnóstico Vascular S.A.S. Diagnóstico Vascular S.A.S. ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af8">
<institution><![CDATA[,Asociación Colombiana de Endocrinología, Diabetes y Metabolismo Asociación Colombiana de Endocrinologían, Diabetes y Metabolismo ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af9">
<institution><![CDATA[,Departamento Medicina Interna Universidad Santiago de Cali ]]></institution>
<addr-line><![CDATA[Cali ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="A10">
<institution><![CDATA[,Departamento Medicina Interna, Floridablanca Universidad Javeriana ]]></institution>
<addr-line><![CDATA[Cali ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="A11">
<institution><![CDATA[,Colsanitas Departamento Medicina Interna ]]></institution>
<addr-line><![CDATA[Cali ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="A12">
<institution><![CDATA[,Colegio Nacional de Bacteriología Colegio Nacional de Bacteriología ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="A13">
<institution><![CDATA[,Dirección científica SYNLAB ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="A14">
<institution><![CDATA[,Fundación Cardiovascular de Colombia Unidad de Métodos Diagnósticos no Invasivos y Clínica de Insuficiencia Cardíaca y Trasplante ]]></institution>
<addr-line><![CDATA[Floridablanca ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="A15">
<institution><![CDATA[,Sociedad Colombiana de Cardiología y Cirugía Cardiovascular Sociedad Colombiana de Cardiología y Cirugía Cardiovascular ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2024</year>
</pub-date>
<volume>31</volume>
<numero>6</numero>
<fpage>329</fpage>
<lpage>335</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0120-56332024000600329&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0120-56332024000600329&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0120-56332024000600329&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción: Las alteraciones del metabolismo lipídico (dislipidemia) son el principal factor de riesgo para el desarrollo de enfermedades cardiovasculares, que son la más importante causa de muerte en el mundo y en Colombia, y un factor que genera un importante consumo de recursos del sistema de salud. Es entonces necesario diseñar y ejecutar estrategias para asegurar un diagnóstico temprano y una evaluación acertada de riesgo cardiovascular, y contar con lineamientos estandarizados para la medición, reporte en el laboratorio e interpretación de los resultados de los perfiles lipídicos, que permitan instaurar medidas preventivas en pacientes con dislipidemia o con riesgo cardiovascular elevado.  Objetivo: Desarrollar un documento estandarizado que resalte la importancia de la medición de los lípidos para la valoración del riesgo cardiovascular, estableciendo criterios unificados para los reportes de laboratorio y metas de tratamiento basadas en el nivel de riesgo.  Método: Por iniciativa conjunta y esfuerzo colaborativo de varias sociedades científicas y de otros actores implicados en el reporte de los lípidos en Colombia, se propuso elaborar, con base en la evidencia disponible y la experiencia de expertos en el tema, un documento enfocado en la importancia de la medición de los lípidos en sangre para la valoración del riesgo cardiovascular y la necesidad de obtener reportes estandarizados y definir metas de tratamiento según el nivel de riesgo.  Resultados: Este artículo es el resultado de un esfuerzo multisocietario, para dar recomendaciones básicas sobre la definición del perfil lipídico y la evaluación del riesgo cardiovascular como un paso necesario para la prevención, toma de decisiones, tratamiento y seguimiento de la enfermedad cardiovascular en Colombia. Se enfatiza en la necesidad de unificar los criterios de análisis y las pautas en los reportes de los perfiles lipídicos en el laboratorio para apoyar la evaluación del riesgo cardiovascular del paciente.  Conclusiones: La estandarización en la medición y en el reporte de los perfiles lipídicos es clave para mejorar la evaluación del riesgo cardiovascular y optimizar las estrategias preventivas y terapéuticas, con miras a alinear las prácticas nacionales con los estándares internacionales.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction: Alterations in lipid metabolism (dyslipidemia) are the main risk factor for the development of cardiovascular diseases, which are the leading cause of death worldwide and in Colombia. They also generate significant resource consumption within the health system. Therefore, it is necessary to design and implement strategies to ensure early diagnosis and accurate cardiovascular risk assessment, along with standardized guidelines for the measurement, laboratory reporting, and interpretation of lipid profile results. This approach allows for the implementation of preventive measures in patients with dyslipidemia or high cardiovascular risk.  Objective: To develop a standardized document emphasizing the importance of lipid measurement in cardiovascular risk assessment, establishing unified criteria for laboratory reports, and defining treatment goals based on risk levels.  Method: Through a joint initiative and collaborative effort of several scientific societies and other stakeholders involved in lipid reporting in Colombia, it was proposed to develop a document based on available evidence and the expertise of subject matter experts. This document focuses on the importance of blood lipid measurement for cardiovascular risk assessment and the necessity of obtaining standardized reports and defining treatment targets according to the level of risk.  Results: This article is the result of a multi-society effort to provide basic recommendations on the definition of the lipid profile and cardiovascular risk assessment as a necessary step for the prevention, decision-making, treatment, and follow-up of cardiovascular disease in Colombia. The need to unify analysis criteria and guidelines in laboratory lipid profile reports is emphasized to support the patient’s cardiovascular risk assessment.  Conclusions: Standardizing lipid profile measurement and reporting is essential to improving cardiovascular risk assessment and optimizing preventive and therapeutic strategies. This consensus represents a key step in aligning national practices with international standards to enhance patient care and reduce the burden of cardiovascular diseases in Colombia.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Enfermedad cardiovascular]]></kwd>
<kwd lng="es"><![CDATA[Lípidos]]></kwd>
<kwd lng="es"><![CDATA[Riesgo cardiovascular]]></kwd>
<kwd lng="es"><![CDATA[Reportes laboratorio]]></kwd>
<kwd lng="es"><![CDATA[Perfil lipídico]]></kwd>
<kwd lng="en"><![CDATA[Cardiovascular disease]]></kwd>
<kwd lng="en"><![CDATA[Lipids]]></kwd>
<kwd lng="en"><![CDATA[Cardiovascular risk]]></kwd>
<kwd lng="en"><![CDATA[Laboratory reports]]></kwd>
<kwd lng="en"><![CDATA[Lipid profile]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alloubani]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Nimer]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Samara]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Relationship between hyperlipidemia, cardiovascular disease and stroke:a systematic review]]></article-title>
<source><![CDATA[Curr Cardiol Rev]]></source>
<year>2021</year>
<volume>17</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<collab>Minsalud conmemora el día mundial del corazón [Internet]</collab>
<source><![CDATA[Bogotá, Colombia:Ministerio de Salud y Protección Social de Colombia]]></source>
<year>2023</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<collab>Conozca las 10 causas de muerte más comunes durante 2023 en Colombia [Internet]</collab>
<source><![CDATA[Infobae]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<collab>DANE</collab>
<source><![CDATA[Estadísticas vitales:Informe técnico, primer trimestre de 2023 n.d]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<collab>DANE</collab>
<article-title xml:lang=""><![CDATA[Estadísticas vitales]]></article-title>
<source><![CDATA[Nacimientos y defunciones [Internet]. Colombia:DANE;junio de 2023]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<collab>Bancode la República de Colombia</collab>
<source><![CDATA[Evolución y carga financiera de las enfermedades crónicas no transmisibles en Colombia:2010-2021 [Internet]]]></source>
<year></year>
<publisher-loc><![CDATA[Colombia ]]></publisher-loc>
<publisher-name><![CDATA[Banco de la República]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Visseren]]></surname>
<given-names><![CDATA[FLJ]]></given-names>
</name>
<name>
<surname><![CDATA[Mach]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Smulders]]></surname>
<given-names><![CDATA[YM]]></given-names>
</name>
<name>
<surname><![CDATA[Carballo]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Koskinas]]></surname>
<given-names><![CDATA[KC]]></given-names>
</name>
<name>
<surname><![CDATA[Bäck]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2021 ESC Guidelines on cardiovascular disease prevention in clinical practice:Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC)]]></article-title>
<source><![CDATA[Rev Esp Cardiol (Engl Ed)]]></source>
<year>2022</year>
<volume>75</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>429</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Herink]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ito]]></surname>
<given-names><![CDATA[MK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medication induced changes in lipid and lipoproteins]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Feingold]]></surname>
<given-names><![CDATA[KR]]></given-names>
</name>
<name>
<surname><![CDATA[Anawalt]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Blackman]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Boyce]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Chrousos]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Corpas]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Endotext [Internet]]]></source>
<year>2000</year>
<publisher-loc><![CDATA[South Dartmouth (MA) ]]></publisher-loc>
<publisher-name><![CDATA[MDText.com]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bays]]></surname>
<given-names><![CDATA[HE]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[PH]]></given-names>
</name>
<name>
<surname><![CDATA[Orringer]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[WV]]></given-names>
</name>
<name>
<surname><![CDATA[Jacobson]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[National Lipid Association annual summary of clinical lipidology 2016]]></article-title>
<source><![CDATA[J Clin Lipidol]]></source>
<year>2016</year>
<volume>10</volume>
<numero>(1 Suppl)</numero>
<issue>(1 Suppl)</issue>
<page-range>S1-S43</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khovidhunkit]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Memon]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Shigenaga]]></surname>
<given-names><![CDATA[JK]]></given-names>
</name>
<name>
<surname><![CDATA[Moser]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
<name>
<surname><![CDATA[Feingold]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of infection and inflammation on lipid and lipoprotein metabolism:mechanisms and consequences to the host]]></article-title>
<source><![CDATA[J Lipid Res]]></source>
<year>2004</year>
<volume>45</volume>
<page-range>1169-96</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pavía-López]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Alcocer-Gamba]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz-Gastelum]]></surname>
<given-names><![CDATA[ED]]></given-names>
</name>
<name>
<surname><![CDATA[Mayorga-Butrón]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Mehta]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz-Aragón]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guía de práctica clínica mexicana para el diagnóstico y tratamiento de las dislipidemias y enfermedad cardiovascular aterosclerótica]]></article-title>
<source><![CDATA[Arch Cardiol Mex]]></source>
<year>2022</year>
<volume>92</volume>
<page-range>1-62</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wilson]]></surname>
<given-names><![CDATA[PWF]]></given-names>
</name>
<name>
<surname><![CDATA[Polonsky]]></surname>
<given-names><![CDATA[TS]]></given-names>
</name>
<name>
<surname><![CDATA[Miedema]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Khera]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kosinski]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Kuvin]]></surname>
<given-names><![CDATA[JT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol:A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2019</year>
<volume>73</volume>
<numero>24</numero>
<issue>24</issue>
<page-range>3210-27</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mach]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Colin]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Alberico]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
<name>
<surname><![CDATA[Konstantino]]></surname>
<given-names><![CDATA[CK]]></given-names>
</name>
<name>
<surname><![CDATA[Manuela]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lina]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guía ESC/EAS 2019 sobre el tratamiento de las dislipemias:modificación de los lípidos para reducir el riesgo cardiovascular]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2020</year>
<volume>73</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>403.e1-403.e70</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barrios]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Escobar]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gamarra]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Obaya]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Pallaré]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Barrios]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comentarios a la guía ESC/EAS 2019 sobre el tratamiento de las dislipemias]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2020</year>
<volume>73</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>348-53</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grundy]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Stone]]></surname>
<given-names><![CDATA[NJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bailey]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Beam]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Birtcher]]></surname>
<given-names><![CDATA[KK]]></given-names>
</name>
<name>
<surname><![CDATA[Blumenthal]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol:A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2019</year>
<volume>139</volume>
<numero>25</numero>
<issue>25</issue>
<page-range>e1186</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vargas-Uricoechea]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Román-González]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Castillo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Merchán]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recomendaciones del panel de expertos sobre la fisiopatología, diagnóstico y tratamiento de las dislipidemias en la población adulta]]></article-title>
<source><![CDATA[Rev Colomb Endocrinol Diabetes Metab]]></source>
<year>2020</year>
<volume>7</volume>
<numero>Supl 1</numero>
<issue>Supl 1</issue>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rubio]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cabrerizo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guías para el tratamiento de las dislipemias en el adulto:Adult Treatment Panel III (ATP-III)]]></article-title>
<source><![CDATA[Endocrinol Nutr]]></source>
<year>2004</year>
<volume>51</volume>
<page-range>254-65</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[GI]]></given-names>
</name>
<name>
<surname><![CDATA[Schreier]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Armonización del estudio de lípidos en el laboratorio clínico]]></article-title>
<source><![CDATA[Acta Bioquim Clin Latinoam]]></source>
<year>2019</year>
<volume>53</volume>
<page-range>459-68</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Plebani]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quality and future of clinical laboratories:the Vico's whole cyclical theory of the recurring cycles]]></article-title>
<source><![CDATA[Clin Chem Lab Med]]></source>
<year>2018</year>
<volume>56</volume>
<page-range>901-8</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Plebani]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Harmonization in laboratory medicine:requests, samples, measurements and reports]]></article-title>
<source><![CDATA[Crit Rev Clin Lab Sci]]></source>
<year>2016</year>
<volume>53</volume>
<page-range>184-96</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Visseren]]></surname>
<given-names><![CDATA[FLJ]]></given-names>
</name>
<name>
<surname><![CDATA[Mach]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Smulders]]></surname>
<given-names><![CDATA[YM]]></given-names>
</name>
<name>
<surname><![CDATA[Carballo]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Koskinas]]></surname>
<given-names><![CDATA[KC]]></given-names>
</name>
<name>
<surname><![CDATA[Bäck]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica, con la contribución especial de la European Association of Preventive Cardiology (EAPC)]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2022</year>
<volume>75</volume>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Armario]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Brotons]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Elosua]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Leciñana]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Castro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Clarà]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Cardiovascular Prevention Guidelines]]></article-title>
<source><![CDATA[Clin Investig Arterioscler]]></source>
<year>2021</year>
<volume>33</volume>
<page-range>85-107</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arrobas]]></surname>
<given-names><![CDATA[VT]]></given-names>
</name>
<name>
<surname><![CDATA[Guijarro]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Campuzano]]></surname>
<given-names><![CDATA[RR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[en representación del Grupo Multidisciplinar de Trabajo de Lípidos y Riesgo Vascular. Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles]]></article-title>
<source><![CDATA[¿Quéparámetros debe incluir un perfil lipídico básico?Clin Investig Arterioscler]]></source>
<year>2023</year>
<volume>35</volume>
<page-range>91-100</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wright]]></surname>
<given-names><![CDATA[IS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Correct levels of serum cholesterol:average vs normal vs optimal]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>1976</year>
<volume>236</volume>
<page-range>261-2</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="">
<collab>Consenso colombiano para el Diagnóstico y tratamiento de dislipidemias en adultos 2024</collab>
<source><![CDATA[Rev Colomb Cardiol]]></source>
<year>2024</year>
<volume>31</volume>
<numero>(Supl4)</numero>
<issue>(Supl4)</issue>
<page-range>2-66</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<collab>Fundación Hipercolesterolemia Familiar</collab>
<article-title xml:lang=""><![CDATA[Diagnóstico clínico y genético de la HF [Internet]]></article-title>
<source><![CDATA[Fundación Hipercolesterolemia Familiar]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pedro-Botet]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Padial]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Brotons]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Esteban-Salán]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[García-Lerín]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Pintó]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Homogeneización de los valores del perfil lipídico]]></article-title>
<source><![CDATA[Clin Investig Arterioscler]]></source>
<year>2018</year>
<volume>30</volume>
<page-range>36-48</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nordestgaard]]></surname>
<given-names><![CDATA[BG]]></given-names>
</name>
<name>
<surname><![CDATA[Langlois]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Langsted]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Chapman]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Aakre]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
<name>
<surname><![CDATA[Baum]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quantifying atherogenic lipoproteins for lipid-lowering strategies:Consensus-based recommendations from EAS and EFLM]]></article-title>
<source><![CDATA[Atherosclerosis]]></source>
<year>2020</year>
<volume>294</volume>
<page-range>46-61</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wilson]]></surname>
<given-names><![CDATA[PWF]]></given-names>
</name>
<name>
<surname><![CDATA[Jacobson]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Jackson]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Le]]></surname>
<given-names><![CDATA[NA]]></given-names>
</name>
<name>
<surname><![CDATA[Davidson]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lipid measurements in the management of cardiovascular diseases:Practical recommendations a scientific statement from the national lipid association writing group]]></article-title>
<source><![CDATA[J Clin Lipidol]]></source>
<year>2021</year>
<volume>15</volume>
<page-range>629-48</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Borén]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Chapman]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Krauss]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Packard]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bentzon]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[Binder]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Low-density lipoproteins cause atherosclerotic cardiovascular disease:pathophysiological, genetic, and therapeutic insights:A consensus statement from the European Atherosclerosis Society Consensus Panel]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2020</year>
<volume>41</volume>
<page-range>2313-30</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
